Literature DB >> 19320443

An activating interaction between the unphosphorylated n-terminus of human liver pyruvate kinase and the main body of the protein is interrupted by phosphorylation.

Aron W Fenton1, Qingling Tang.   

Abstract

The initial 26 amino acids of human liver pyruvate kinase (L-PYK) are not present/observed in the crystal structure. This region includes Ser12, the site of hormone-dependent phosphorylation. Truncating the N-terminus of L-PYK mimics the effects of phosphorylation by causing a decrease in apparent phosphoenolpyruvate (PEP) affinity. An N-terminus truncation series was used to map the minimum number of residues that could be removed to result in the decrease in apparent PEP affinity. Results are consistent with a mechanism by which phosphorylation at Ser12 interrupts an activating interaction of N-terminal residues (including those at positions 7-10) with the main body of the protein, as a means of inhibiting substrate affinity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320443      PMCID: PMC2714166          DOI: 10.1021/bi900421f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  26 in total

1.  Amino acid sequence at the phosphorylated site of rat liver pyruvate kinase.

Authors:  B Edlund; J Andersson; V Titanji; U Dahlqvist; P Ekman; O Zetterqvist; L Engstoöm
Journal:  Biochem Biophys Res Commun       Date:  1975-12-15       Impact factor: 3.575

2.  Comparative kinetic studies on the L-type pyruvate kinase from rat liver and the enzyme phosphorylated by cyclic 3', 5'-AMP-stimulated protein kinase.

Authors:  P Ekman; U Dahlqvist; E Humble; L Engström
Journal:  Biochim Biophys Acta       Date:  1976-04-08

3.  Rapid reciprocal changes of hepatic glycolytic enzymes and fructose-1,6-diphosphatase following glucagon and insulin injection in vivo.

Authors:  O D Taunton; F B Stifel; H L Greene; R H Herman
Journal:  Biochem Biophys Res Commun       Date:  1972-09-26       Impact factor: 3.575

4.  Rapid reciprocal changes in rat hepatic glycolytic enzyme and fructose diphosphatase activities following insulin and glucagon injection.

Authors:  O D Taunton; F B Stifel; H L Greene; R H Herman
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

5.  Rapid reciprocal changes in rat tissue enzyme activities following epinephrine injection.

Authors:  F B Stifel; O D Taunton; H L Greene; R H Herman
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

6.  Amino acid sequence of a (32P) phosphopeptide from pig liver pyruvate kinase phosphorylated by cyclic 3',5'-AMP-stimulated protein kinase and gamma-(32P)ATP.

Authors:  G Hjelmquist; J Andersson; B Edlund; L Engstroöm
Journal:  Biochem Biophys Res Commun       Date:  1974-11-27       Impact factor: 3.575

7.  Ligand binding and internal equilibria in proteins.

Authors:  G Weber
Journal:  Biochemistry       Date:  1972-02-29       Impact factor: 3.162

8.  Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia.

Authors:  Giovanna Valentini; Laurent R Chiarelli; Riccardo Fortin; Manuela Dolzan; Alessandro Galizzi; Donald J Abraham; Changqing Wang; Paola Bianchi; Alberto Zanella; Andrea Mattevi
Journal:  J Biol Chem       Date:  2002-04-17       Impact factor: 5.157

9.  The rapid changes of hepatic glycolytic enzymes and fructose-1,6-diphosphatase activities after intravenous glucagon in humans.

Authors:  H L Greene; O D Taunton; F B Stifel; R H Herman
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

10.  The pH dependence of the allosteric response of human liver pyruvate kinase to fructose-1,6-bisphosphate, ATP, and alanine.

Authors:  Aron W Fenton; Myra Hutchinson
Journal:  Arch Biochem Biophys       Date:  2009-01-20       Impact factor: 4.013

View more
  15 in total

1.  Whole-protein alanine-scanning mutagenesis of allostery: A large percentage of a protein can contribute to mechanism.

Authors:  Qingling Tang; Aron W Fenton
Journal:  Hum Mutat       Date:  2017-06-16       Impact factor: 4.878

2.  Chokepoints in Mechanical Coupling Associated with Allosteric Proteins: The Pyruvate Kinase Example.

Authors:  Lewis E Johnson; Bojana Ginovska; Aron W Fenton; Simone Raugei
Journal:  Biophys J       Date:  2019-04-02       Impact factor: 4.033

3.  Probing L-pyruvate kinase regulatory phosphorylation site by mutagenesis.

Authors:  Ilona Faustova; Mart Loog; Jaak Järv
Journal:  Protein J       Date:  2012-10       Impact factor: 2.371

4.  Distinguishing the interactions in the fructose 1,6-bisphosphate binding site of human liver pyruvate kinase that contribute to allostery.

Authors:  Arjun Ishwar; Qingling Tang; Aron W Fenton
Journal:  Biochemistry       Date:  2015-02-12       Impact factor: 3.162

5.  Identification of allosteric-activating drug leads for human liver pyruvate kinase.

Authors:  Aron W Fenton
Journal:  Methods Mol Biol       Date:  2012

6.  Allosteric regulation of human liver pyruvate kinase by peptides that mimic the phosphorylated/dephosphorylated N-terminus.

Authors:  Charulata B Prasannan; Qingling Tang; Aron W Fenton
Journal:  Methods Mol Biol       Date:  2012

7.  The impact of ions on allosteric functions in human liver pyruvate kinase.

Authors:  Aron W Fenton; Aileen Y Alontaga
Journal:  Methods Enzymol       Date:  2009-11-13       Impact factor: 1.600

8.  Energetic coupling between an oxidizable cysteine and the phosphorylatable N-terminus of human liver pyruvate kinase.

Authors:  Todd Holyoak; Bing Zhang; Junpeng Deng; Qingling Tang; Charulata B Prasannan; Aron W Fenton
Journal:  Biochemistry       Date:  2013-01-11       Impact factor: 3.162

9.  Are all regions of folded proteins that undergo ligand-dependent order-disorder transitions targets for allosteric peptide mimetics?

Authors:  Aron W Fenton
Journal:  Biopolymers       Date:  2013-11       Impact factor: 2.505

10.  Distinct Hepatic PKA and CDK Signaling Pathways Control Activity-Independent Pyruvate Kinase Phosphorylation and Hepatic Glucose Production.

Authors:  Brandon M Gassaway; Rebecca L Cardone; Anil K Padyana; Max C Petersen; Evan T Judd; Sebastian Hayes; Shuilong Tong; Karl W Barber; Maria Apostolidi; Abudukadier Abulizi; Joshua B Sheetz; Hans R Aerni; Stefan Gross; Charles Kung; Varman T Samuel; Gerald I Shulman; Richard G Kibbey; Jesse Rinehart
Journal:  Cell Rep       Date:  2019-12-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.